<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Michael J. Evans:  Law + Technology + Marketing &#187; FDA</title>
	<atom:link href="http://www.mjevans.com/tag/fda/feed" rel="self" type="application/rss+xml" />
	<link>http://www.mjevans.com</link>
	<description>How lawyers can use the Internet, social media, online video, and technology to attract clients, be more effective, make more money, and have more fun.</description>
	<lastBuildDate>Sat, 21 Aug 2010 05:25:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Yaz, Yasmin ads must be updated to add risks of thromboembolism</title>
		<link>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism</link>
		<comments>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism#comments</comments>
		<pubDate>Mon, 19 Apr 2010 16:49:47 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[thromboembolism]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yaz]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=785</guid>
		<description><![CDATA[The Food and Drug Administration is requiring Bayer, the maker of Yaz/Yasmin birth control pills, to change its ads and promotional materials to add information about the risk of thromboembolism.  Bayer recently changed the drugs&#8217;s warning labels to include information about the risk of thromboembolism in women using Yasmin compared to contraceptives using other progestins. [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/yaz-yasmin-ads-must-be-updated-to-add-risks-of-thromboembolism/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gardasil Researcher Drops Bombshell(s)</title>
		<link>http://www.mjevans.com/miscellaneous/gardasil-researcher-drops-bombshells</link>
		<comments>http://www.mjevans.com/miscellaneous/gardasil-researcher-drops-bombshells#comments</comments>
		<pubDate>Tue, 03 Nov 2009 11:21:46 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[Miscellaneous]]></category>
		<category><![CDATA[Cervaris]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[Gardasil Side-Effects]]></category>
		<category><![CDATA[HPV Vaccine]]></category>
		<category><![CDATA[HPV Vaccine Side-Effects]]></category>
		<category><![CDATA[Merck]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=706</guid>
		<description><![CDATA[According to an excellently reported article by Susan Brinkmann for the Philadelphia Daily Bulletin, Dr. Diane Harper, the lead researcher during clinical trials of two human papiloma vaccines, Gardasil and Cervarix, dropped a bombshell (or perhaps multiple bombshells) at the 4th International Public Conference on Vaccination.  Dr. Harper said the drugs will do little to [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/miscellaneous/gardasil-researcher-drops-bombshells/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Finally, an FDA that may care more about consumer protection than politics.</title>
		<link>http://www.mjevans.com/dangerous-products/finally-an-fda-that-may-care-more-about-consumer-protection-than-politics</link>
		<comments>http://www.mjevans.com/dangerous-products/finally-an-fda-that-may-care-more-about-consumer-protection-than-politics#comments</comments>
		<pubDate>Fri, 23 Oct 2009 23:19:56 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Patient Safety]]></category>
		<category><![CDATA[Politics]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=694</guid>
		<description><![CDATA[The New York Times reported September 24, 2009 that the Food and Drug Administration (FDA) admitted &#8220;that four New Jersey congressmen and its own former commissioner unduly influenced the process that led to its decision last year to approve a patch for injured knees, an approval it is now revisiting.&#8221; [Blogger's note: all emphasized text [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/finally-an-fda-that-may-care-more-about-consumer-protection-than-politics/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA warns consumers not to use Hydroxycut products due to liver risks</title>
		<link>http://www.mjevans.com/dangerous-products/fda-warns-consumers-not-to-use-hydroxycut-products-due-to-liver-risks</link>
		<comments>http://www.mjevans.com/dangerous-products/fda-warns-consumers-not-to-use-hydroxycut-products-due-to-liver-risks#comments</comments>
		<pubDate>Tue, 05 May 2009 03:38:57 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[consumers]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Hydroxycut]]></category>
		<category><![CDATA[liver disease]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=462</guid>
		<description><![CDATA[The Food and Drug Administration (FDA) has issued a warning to consumers not to use Hydroxycut products due to the risk of serious liver damage.  The FDA says that &#8220;Consumers who use a Hydroxycut dietary supplement and who experience signs of illness associated with liver disease should immediately consult their health care provider.  Symptoms of [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/fda-warns-consumers-not-to-use-hydroxycut-products-due-to-liver-risks/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA requires &#8220;Black Box&#8221; warning for Botox, Myobloc and Dysport</title>
		<link>http://www.mjevans.com/dangerous-products/fda-requires-black-box-warning-for-botox-myobloc-and-dysport</link>
		<comments>http://www.mjevans.com/dangerous-products/fda-requires-black-box-warning-for-botox-myobloc-and-dysport#comments</comments>
		<pubDate>Tue, 05 May 2009 02:55:11 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[Black Box warning]]></category>
		<category><![CDATA[Botox]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[drug side-effects]]></category>
		<category><![CDATA[Dysport]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Myobloc]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=456</guid>
		<description><![CDATA[The FDA has announced that it will require a &#8220;Black Box&#8221; warning on Botox and its competitors due to serious adverse side-effects.  Many of the side-effects have been reported when Botox has been used as an off-label treatment for children with cerebral palsy.  Side-effects in children have included difficulty breathing, difficulty swallowing, muscular weakness, drooping [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/fda-requires-black-box-warning-for-botox-myobloc-and-dysport/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Texas appeals court rules woman can go to trial on claim that Prempro caused breast cancer</title>
		<link>http://www.mjevans.com/dangerous-products/texas-appeals-court-rules-woman-can-go-to-trial-on-claim-that-prempro-caused-breast-cancer</link>
		<comments>http://www.mjevans.com/dangerous-products/texas-appeals-court-rules-woman-can-go-to-trial-on-claim-that-prempro-caused-breast-cancer#comments</comments>
		<pubDate>Tue, 21 Apr 2009 22:05:27 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[preemption]]></category>
		<category><![CDATA[Prempro]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=329</guid>
		<description><![CDATA[A Texas appeals court has ruled that Wyeth must face a lawsuit by a woman who claims her breast cancer was caused by the hormone replacement drug Prempro, according to a Bloomberg article.  The appeals court cited the U.S. Supreme Court&#8217;s recent decision in Wyeth v. Levine rejecting Big Pharma&#8217;s argument that FDA approval barred [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/texas-appeals-court-rules-woman-can-go-to-trial-on-claim-that-prempro-caused-breast-cancer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genentech recalls psoriasis drug Raptiva</title>
		<link>http://www.mjevans.com/dangerous-products/genentech-recalls-psoriasis-drug-raptiva</link>
		<comments>http://www.mjevans.com/dangerous-products/genentech-recalls-psoriasis-drug-raptiva#comments</comments>
		<pubDate>Fri, 10 Apr 2009 02:41:35 +0000</pubDate>
		<dc:creator>Michael J. Evans</dc:creator>
				<category><![CDATA[Consumer Protection]]></category>
		<category><![CDATA[Dangerous Products]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Raptiva]]></category>
		<category><![CDATA[recall]]></category>

		<guid isPermaLink="false">http://www.mjevans.com/?p=287</guid>
		<description><![CDATA[The FDA announced yesterday that Genentech was withdrawing the psoriasis drug Raptiva because of a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML), a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system.  There is no known effective treatment for PML. About 2,000 people in the U.S. [...]]]></description>
		<wfw:commentRss>http://www.mjevans.com/dangerous-products/genentech-recalls-psoriasis-drug-raptiva/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
